ARK
Compare
Buy

ARK Genomic Revolution ETFARKG

ARKSectorsHealth Care#2 of 264 by YTD

$49.51

+2.5% last session

+70.9% YTD

Data as of 11/3/20264:00 PM ET · End-of-day

0%+25%+50%+75%S&P 500 +11.5%High +89.2%+70.9%Dec 31, 2025Nov 3, 20260%+25%+50%+75%S&P 500 +11.5%High +89.2%+70.9%Dec 31, 2025Nov 3, 2026
Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 3, 2026ARKGS&P 500 · VOO
@TheETFTracker·theetftracker.com
Returns1D1M3MYTD1Y3Y5YMAX
Total return+2.5%−12.8%+20.1%+70.9%+59.0%+122.6%−34.1%+166.0%
Peer average+0.6%+4.0%+6.1%+21.0%+29.0%+81.2%+28.9%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%—
AUM
$2.2B
Expense ratio
0.75%
Distribution yield
0.0%
NAV
$48.33
Volume
4.8M
Avg. volume 30D
5.7M
High today
$50.80
Low today
$48.79
Previous close
$48.29
52-week high
$58.83
52-week low
$24.60
Our risk indicator
4/5

ARKG in One Breath

ARKG Among Health Care ETFs

YTD
#1ARKGARK+70.9%$2.2B
#2IDNAiShares+62.8%$340M
#3BBHVanEck+35.0%$525M
#4FTXHFirst Trust+33.8%$1.2B
#5XHSSPDR+32.9%$229M
#6BBPVirtus+29.5%$132M
#7XBISPDR+27.2%$10.5B
#8IHEiShares+26.9%$1.6B
#9PSCHInvesco+25.9%$178M
End-of-day Nov 4, 2026 · 33 Health care ETFs by YTD
@TheETFTracker·theetftracker.com

$10,000 in ARKG

5Y
$10,000 in ARKG became
$6,586
In the S&P 500 (VOO)
$17,749
$5K$10K$15K$6,586 ARKG$17,749 VOOlow $2,879Oct 2021Nov 2026
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
@TheETFTracker·theetftracker.com

ARKG’s Top Holdings

Today
ARK ARKG · 10 holdings · tile size = share of the fund · as of Nov 3, 2026
@TheETFTracker·theetftracker.com

What ARKG Holds

Today
Biotechnology49.6%
TXG 7.5 · TWST 7.4 · CRSP 5.5 · ABSI 5.1 · BEAM 3.8 · RXRX 2.9 · NRIX 2.9
Medical - Diagnostics & Research25.7%
GH 5.1 · NTRA 4.7 · CDNA 4.5 · ILMN 4.3 · VCYT 3.8 · WGS 1.7 · FRNM
Medical - Healthcare Information Services9.8%
TEM 9.8
Drug Manufacturers - General4.6%
LLY 4.6
Software - Application3.8%
SDGR 2.9 · IAM
Medical - Devices3.8%
BFLY 1.5 · PACB 1.3 · CERS
Medical - Specialties1.0%
MASS
ARK ARKG · share of the fund by industry · as of Nov 3, 2026
@TheETFTracker·theetftracker.com

Tempus’ Share of ARKG

Today
9.8%

$98 of every $1,000 in ARKG is Tempus

Tempus held by ARKG
$219M
Most Tempus per dollar
ARKG9.8%
ARKK6.3%
HEAL4.6%
WDNA3.4%
ARK ARKG · each square = $10 of $1,000 · as of Nov 3, 2026
@TheETFTracker·theetftracker.com

ARKG’s Share of Health Care ETFs

Today
2.0%

of the $109B in 39 Health care ETFs

ARKG
ARKG$2.2B2.0%
XLV$49.1B45.0%
VHT$19.1B17.5%
36 others$38.6B35.4%
Health care ETF AUM · Nov 4, 2026
@TheETFTracker·theetftracker.com

ARKG Fee per $100 vs Peers

Today
$0.75a year
per $100
$75 a year on $10,000
XLV$0.08
VHT$0.09
XBI$0.35
IYH$0.37
IXJ$0.38
ARKG$0.75
Expense ratio · Health care peers · Nov 4, 2026
@TheETFTracker·theetftracker.com

Inside ARKG

10 holdings · as of Nov 3, 2026
ARKG

ARK Genomic Revolution ETF

Today
#TickerCompanyWeight ▼
1TEMTempus AI -9.85%
2TXG10X Genomics -7.52%
3TWSTTwist Bioscience7.42%
4CRSPCrispr Therapeutics AG5.48%
5GHGuardant Health5.13%
6ABSIAbsci5.08%
7NTRANatera4.67%
8LLYELI Lilly &4.59%
9CDNACaredx4.50%
10ILMNIllumina4.26%
BiotechnologyMedical - DiagnosticsMedical - Healthcare Information ServicesDrug Manufacturers - GeneralSoftware - ApplicationMedical - DevicesMedical - SpecialtiesOther
ARK ARKG · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 84.6%
@TheETFTracker·theetftracker.com

How It Compares

ARKG

ARK Genomic Revolution ETF’s Peers

1Y
Trend
XLVSPDRReadDesk0.08%+29.7%+20.4%$49.1B
VHTVanguardReadDesk0.09%+28.1%+19.6%$19.1B
XBISPDRReadDesk0.35%+38.1%+27.2%$10.5B
IYHiSharesReadDesk0.37%+28.6%+19.8%$4.7B
IXJiSharesReadDesk0.38%+24.7%+16.0%$4.6B
ARKGARKThis fundReadDesk0.75%+59.0%+70.9%$2.2B
Health care peers · Past-year and ytd returns · as of Nov 4, 2026 · sorted by AUM
@TheETFTracker·theetftracker.com

XLV vs ARKG

YTD
XLVSPDR · Health careARKGARK · Health care
Year to date
ARKG wins+50.5 pts
Past year
ARKG wins+29.3 pts
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV22.1× more
2–2level
SPDR XLV and ARK ARKG · year-to-date · as of Nov 4, 2026 · AUM not scored
@TheETFTracker·theetftracker.com

ARKG vs VOO

1Y
ARKG · ARK Genomic Revolution
+59.0%
VOO · S&P 500
+11.9%
Gap
47.2 pts
0%+25%+50%+59.0% ARKG+11.9% VOONov 4, 2025Nov 4, 20260%+50%+59.0% ARKG+11.9% VOONov 4, 2025Nov 4, 2026
ARK ARKG and Vanguard VOO · 1Y total return · as of Nov 4, 2026
@TheETFTracker·theetftracker.com

ARKG vs Its Peer Average

YTD
ARKGAvsBPeer average
1D+2.5%+0.6%
1M−12.8%+4.0%
3M+20.1%+6.1%
YTD+70.9%+21.0%
1Y+59.0%+29.0%
3Y+122.6%+81.2%
5Y−34.1%+28.9%
5–2ARKG wins
38 Health care peers · each row scaled to its leader
@TheETFTracker·theetftracker.com

The Details

ARKG

Risk

1Y
4/5our risk indicator
CalmerBumpier
Volatility · 1Y45.81%
Deepest drop · 1Y−27.5%
Lowest point · 5Y−73.7%
52-week range
$24.60−15.8% from the high$58.83
ARK ARKG · past-year price moves · as of Nov 4, 2026
@TheETFTracker·theetftracker.com
ARKG

Payouts by Year

5Y
$0.38per share, Dec 2021
$0.332017’18$1.05’19’20$0.382021
Distribution yield0.0%
PaidOnce a year, in December
Latest ex-date · paidDec 29 · Dec 31, 2021
5 payouts added up$3.02 a share
ARK ARKG · distributions by ex-date · 2017–2021
@TheETFTracker·theetftracker.com
All Fund FactsDocuments · trading · fees · every payout

Prospectus & Documents

SEC reported portfolio · 2026-07-31 ↗SEC reported portfolio · 2026-04-30 ↗SEC reported portfolio · 2026-01-30 ↗SEC reported portfolio · 2025-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-07-31 ↗SEC reported portfolio · 2025-04-30 ↗SEC reported portfolio · 2025-01-31 ↗SEC reported portfolio · 2024-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-07-31 ↗SEC reported portfolio · 2024-04-30 ↗SEC reported portfolio · 2024-01-31 ↗SEC reported portfolio · 2023-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-07-31 ↗SEC reported portfolio · 2023-04-28 ↗SEC reported portfolio · 2023-01-31 ↗SEC reported portfolio · 2022-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-07-29 ↗SEC reported portfolio · 2022-04-29 ↗SEC reported portfolio · 2022-01-31 ↗SEC reported portfolio · 2021-10-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-07-30 ↗SEC reported portfolio · 2021-04-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-01-29 ↗SEC reported portfolio · 2020-10-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-07-31 ↗SEC reported portfolio · 2020-04-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗

Trading & Liquidity

Net asset value$48.33
Premium / discount[…]
Median spread · 30D[…]
Volume today4.8M
Average volume · 30D5.7M
Shares outstanding[…]
Options[…]

Fees & Costs

Net expense ratio0.75%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$75.00
Our risk indicator4/5

Estimated yearly cost excludes trading costs and assumes constant assets.

Distributions

Ex-datePaidPer share
Dec 29, 2021Dec 31, 2021$0.38
Dec 29, 2020Dec 31, 2020$0.79
Dec 27, 2019Dec 31, 2019$1.05
Dec 27, 2018Dec 31, 2018$0.47
Dec 27, 2017Dec 29, 2017$0.33
Issuer contentFrom ARKHear the strategy from the people behind ARKG.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →